{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-005961","form_type":"8-K","ticker":"EXOZ","cik":"0002010788","company_name":"EXOZYMES INC.","filed_at":"2025-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.788838+00:00","generated_at":"2026-05-26T23:32:03.848163+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Invizyne Technologies renamed eXoZymes Inc. effective Feb 10, 2025","bullets":["Name changed from Invizyne Technologies Inc. to eXoZymes Inc. via certificate of amendment filed Feb 10, 2025.","Trading symbol remains EXOZ on Nasdaq Capital Market; no ticker change announced.","Principal executive offices in Monrovia, CA, and Nevada incorporation unchanged.","No changes to business operations, management, or financial guidance disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-005961","json":"https://secwatch.observer/filing/0001493152-25-005961.json","markdown":"https://secwatch.observer/filing/0001493152-25-005961.md","text":"https://secwatch.observer/filing/0001493152-25-005961.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2010788/000149315225005961/0001493152-25-005961-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2010788/000149315225005961/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T23:32:03.848163+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}